A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)

Clinical trial NCT03455140 · COMPLETED

Trial details

NCT number: NCT03455140
Sponsor: University of Birmingham
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Pediatric Solid Tumor Pediatric AML Pediatric ALL

Start date: 2018-08-28
Primary completion: 2022-07-22
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.